Breast-conservation treatment for patients with ductal carcinoma in situ

Oncology Reports

Volumn 7, Issue 6, 2000, Pages 1247-1252

  Terashima, Masako ^a   Ogawa, Yasuhiro ^a   Kariya, Shinji ^a   Inomata, Taisuke ^a   Nishioka, Akihito ^a   Shimizu, Kazuto ^a   Yamanishi, Tomoaki ^a   Tanaka, Yohsuke ^a   Tochika, Naoshige ^a   Yoshida, Shoji ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Breast cancer; Conservation treatment; Ductal carcinoma in situ

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CAF PROTOCOL 2; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG DERIVATIVE; FLUOROURACIL; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TOREMIFENE;

ADULT; ARTICLE; BREAST TUMOR; CARCINOMA IN SITU; CLINICAL TRIAL; FEMALE; HUMAN; MAMMOGRAPHY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET NIPPLE DISEASE; RADIOGRAPHY; RADIOTHERAPY; SEGMENTAL MASTECTOMY;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR MODULATORS; FEMALE; FLUOROURACIL; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RADIOTHERAPY; TAMOXIFEN; TOREMIFENE;

EID: 0034323373     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.6.1247     Document Type: Article

References (23)

1. Jacobson JA, Danforth DN, Cowan KH, et al:. Ten-year results of a compression of conservation with mastectomy in the treatment of stage I and stage II breast cancer. N Engl J Med 332: 907-911, 1995.
2. Vinci FA, Goldstein NS and Kestin LL: Pathologic and technical considerations in the treatment of ductal carcinoma in situ of the breast with lumpectomy and radiation therapy. Ann Oncol 10: 883-890, 1999.
3. Leibel SA and Phillips TL: Breast cancer. In: Textbook of Radiation Oncology. W.B. Saunders Co., Pennsylvania, pp1021, 1998.
4. Anderson TJ, Lamb J, Donnan P, et al: Comparative pathology of breast cancer in a randomized trial of screening. Br J Cancer 64: 108-113,1991.
5. Ogawa Y, Nishioka A, Inomata T, et al: Conservation treatment intensified with tamoxifen and CAF chemotherapy for subareolar breast cancers. Oncol Rep 5: 1337-1341, 1998.
6. Ogawa Y, Nishioka A, Inomata T, et al: Conservation treatment intensified with tamoxifen and CAF chemotherapy without axillary dissection for early breast cancer patients with clinically-negative axillary nodes. Oncol Rep 6: 801-805, 1999.
7. Ogawa Y, Nishioka A, Inomata T, et al: Conservation treatment intensified with an anti-estrogen agent and CAF chemotherapy for stage I and II breast cancer. Oncol Rep 7: 479-484, 2000.
8. Hata Y, Ogawa Y, Inomata T, et al: Thin section CT in the prone position for detection of axillary lymph node metastases in breast cancer. Oncol Rep 5: 1403-1406, 1998.
9. Nishioka A, Ogawa Y, Hamada N, et al: Analysis of radiation pneumonitis and radiation-induced lung fibrosis in breast cancer patients after breast-conservation treatment. Oncol Rep 6: 513-517, 1999.
10. Tsuboi N, Ogawa Y, Inomata T, et al: Changes in the findings of dynamic MRI by preoperative CAF chemotherapy for patients with breast cancer of stage II and III: pathologic correlation. Oncol Rep 6: 727-732, 1999.
11. Habel LA, Daling JR, Newcomb PA, et al: Risk of recurrence after ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 7: 689-696, 1998.
12. Silverstein MJ, Lagios MD, Groshen S, et al: The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340: 1455-1461, 1999.
13. Cancer Control Agency of British Columbia: Treatment of breast tumors. In: Cancer Treatment Policies. 3rd edition. Cancer Control Agency of British Columbia, Vancouver, pp25-102, 1988.
14. Hiramatsu H, Enomoto K, Ikeda T, et al: Three-dimensional helical CT for treatment planning of breast cancer. Radiat Med 17: 35-40, 1999.
15. Akashi-Tanaka T, Fukutomi T, Miyakawa K, et al: Clinical use of contrast-enhanced computed tomography for decision making in breast conserving surgery. Breast Cancer 4: 280-284, 1997.
16. Daniel BL, Yen YF, Glover GH, et al: Breast disease: dynamic spiral MR imaging. Radiology 209: 499-509, 1998.
17. Winchester DP and Cox JD: Standards for breast-conservation treatment. CA-A Cancer J Clin 42: 134-162, 1992.
18. Sakamoto I, Hama Y and Akiyama F: The present status of histopathologic diagnosis of non-invasive ductal carcinoma of the breast. Jpn J Cancer Clin 46: 71-77, 2000.
19. Gage I and Harris JR: Radiation therapy and breast cancer. Curr Opin Oncol 10: 513-516, 1998.
20. Zafrani B, Leroyer A, Fourquet A, et al: Mammographically-detected ductal carcinoma in situ of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins and proliferative activity. Semin Diagn Pathol 11: 208-214, 1994.
21. Leal CB, Schmitt FC, Bento MJ, et al: Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein. Cancer 75: 2123-2131, 1995.
22. Jacquillat C, Weil M and Baillet T: Results of neoadjuvant chemotherapy and radiation therapy in the breast conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 66: 114-119, 1990.
23. Mauriac L, Durand M, Avril A and Dilhuydy JM: Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single center. Ann Oncol 2: 347-354, 1991.